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In this paper, the authors analyze the evolution of the Mexican legal framework that
culminated in the creation of the System of Social Protection in Health (SSPH) and its
operative branch, Popular Health Insurance or Seguro Popular. This insurance scheme
extended health care coverage with financial protection to all Mexicans citizens in 2012.
First, we discuss the nature of social rights, including the right to health care. The
authors then describe the evolution of the contents of the legal instruments (the
Constitution, the social security laws and the General Health Law) that supported the
transition in Mexico from health care as the subject of charity to health care as a labor
right and then as a social or citizen right. Finally, the authors discuss how the creation
of the SSPH established the regulatory and financial conditions to guarantee the exercise
of the right to the protection of health. There are three lessons of the evolution of the
framework that gave legal support to the expansion of health coverage in Mexico. First,
the introduction of the right to the protection of health into the Mexican Constitution in
1983 identified UHC as an achievable vision. Second, the establishment of the SSPH
placed access to comprehensive health care outside of the public assistance realm,
guaranteeing its justiciability and establishing the rules to assure its financial
sustainability. Finally, the recent Mexican reform illustrates the potential to expand
coverage with financial protection to reach the poor and non-salaried workers by
decoupling access to social protection in health from salaried employment and
transforming it into a right of citizenship.
Duty to Warn of the Risk of HIV/AIDS Infection in Africa: An Appropriate Legal
Response?
Dr. Obiajulu Nnamuchi & Dr. Remigius N. Nwabueze

................................

386

The central concern of this paper is to determine whether a physician who competently
diagnosed an African female patient of HIV/AIDS infection has a legal obligation to
disclose the test result to the patient's husband or partner. The paper argues that
although most western jurisdictions have settled in favor of disclosure, this is not a
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sufficient warrant for adopting a similar regime in Africa. It advocates an Africentric
response, one that focuses squarely on the vulnerable circumstances of women in Africa
and the havoc that would be wrought in these women's lives and well-being by the
imposition of a mandatory disclosure framework.
Prosecutions of Pharmaceutical Companies for Off-Label Marketing: Fueled By
Government's Desire to Modify Corporate Conduct or Pursuit of a Lucrative
Revenue Stream?
Lise T. Spacapan & Jill M. Hutchison
........................................
407
Every year, health care fraud and abuse places a significant financial strain on the
federal government. This article specifically discusses fraud and abuse cases involving
pharmaceutical companies that allegedly promote their products for off-label purposes,
which are not approved by the United States Food and Drug Administration. First, the
authors provide a discussion of the applicable federal regulations under the Federal
Food, Drug and Cosmetic Act. Next, the authors look at the Department of Justice's
enforcement of regulatory violations and call into question the DOJ's aggressive
approach. The authors then provide several examples of government prosecutions and
spotlight some of the fundamental challenges to those prosecutions. The authors then
discuss the added financial costs following DOJ scrutiny and the relevant health policy
issues that are implicated. In conclusion, the authors question whether these current
trends in government conduct actually benefit the public or simply generate a substantial
revenue strean
Dear Doctor Letters: Lessons in Statutory Interpretation, Preemption, Proximate
Causation, and Subsequent-Remedial Measures
James W. Huston, Ellen Nudelman Adler & Joanna L. Simon
................. 445
In this article, the authors discuss the current use and the potential legal implications of
Dear Doctor letters. Dear Doctor letters are used to communicate important information
between pharmaceutical manufacturers and the professionals who prescribe and
administer drugs. This article first discusses the applicable FDAregulations and
guidance material, including the standards for when, how, and to whom Dear Doctor
letters should be issued. Next, the article reviews the extent to which federal preemption
principles apply to Dear Doctor letters as outlined by the Supreme Court in the landmark
case Pliva v. Mensing. The article then analyzes the role of Dear Doctor letters in
litigation in a post-Mensing world, including whether Dear Doctor letters can be used to
show causation and whether Dear Doctor letters are admissible evidence at trial. The
article concludes with practical tips related to sending out Dear Doctor letters.
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